Galera, P.; Iglesias-Beiroa, A.; Hernández-Marín, B.; Bañón, D.; Arangoa, T.; Castillo, L.; Álvarez-Maldonado, M.; Gil-Olarte, C.; Borregón, R.; Iribarren, M.;
et al. Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer. Curr. Oncol. 2025, 32, 583.
https://doi.org/10.3390/curroncol32100583
AMA Style
Galera P, Iglesias-Beiroa A, Hernández-Marín B, Bañón D, Arangoa T, Castillo L, Álvarez-Maldonado M, Gil-Olarte C, Borregón R, Iribarren M,
et al. Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer. Current Oncology. 2025; 32(10):583.
https://doi.org/10.3390/curroncol32100583
Chicago/Turabian Style
Galera, Paloma, Antía Iglesias-Beiroa, Berta Hernández-Marín, Dulce Bañón, Teresa Arangoa, Lucía Castillo, María Álvarez-Maldonado, Cristina Gil-Olarte, Rafael Borregón, María Iribarren,
and et al. 2025. "Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer" Current Oncology 32, no. 10: 583.
https://doi.org/10.3390/curroncol32100583
APA Style
Galera, P., Iglesias-Beiroa, A., Hernández-Marín, B., Bañón, D., Arangoa, T., Castillo, L., Álvarez-Maldonado, M., Gil-Olarte, C., Borregón, R., Iribarren, M., Colomer, R., & Rogado, J.
(2025). Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer. Current Oncology, 32(10), 583.
https://doi.org/10.3390/curroncol32100583
